frontpage.

So I have a typical medium-sized Rails codebase, but with significant code that's not the dead simple CRUD stuff. For example, it talks with third-party APIs, does user authentication, uses Postgres FTS plus some other things.

I'm bored to work on it lately, and I was thinking whether using an LLM I could implement new features for it.

Are any of the current models at this point yet? I guess it should need to have a big context so that it reads all the views/controllers/models.

If so, which tool would you use? Something like Codex or Claude Code?

Achieving Ultra-Fast AI Chat Widgets

Show HN: Runtime Fence – Kill switch for AI agents

Researchers surprised by the brain benefits of cannabis usage in adults over 40

Peter Thiel warns the Antichrist, apocalypse linked to the 'end of modernity'

USS Preble Used Helios Laser to Zap Four Drones in Expanding Testing

Show HN: Animated beach scene, made with CSS

An update on unredacting select Epstein files – DBC12.pdf liberated

Was going to share my work

Pitchfork: A devilishly good process manager for developers

You Are Here

Why social apps need to become proactive, not reactive

How patient are AI scrapers, anyway? – Random Thoughts

Vouch: A contributor trust management system

I built a terminal monitoring app and custom firmware for a clock with Claude

Tiny C Compiler

Y Combinator Founder Organizes 'March for Billionaires'

Ask HN: Need feedback on the idea I'm working on

OpenClaw Addresses Security Risks

Apple finalizes Gemini / Siri deal

Italy Railways Sabotaged

Emacs-tramp-RPC: high-performance TRAMP back end using MsgPack-RPC

Nintendo Wii Themed Portfolio

"There must be something like the opposite of suicide "

Ask HN: Why doesn't Netflix add a “Theater Mode” that recreates the worst parts?

Show HN: Engineering Perception with Combinatorial Memetics

Show HN: Steam Daily – A Wordle-like daily puzzle game for Steam fans

The Anthropic Hive Mind

Just Started Using AmpCode

LLM as an Engineer vs. a Founder?

Crosstalk inside cells helps pathogens evade drugs, study finds